Multidrug-resistant strains of Shigella dysenteriae type 1 were implicated in three outbreaks and sporadic cases of dysentery in eastern India in 2002 and 2003. After a hiatus of 14 years, this pathogen reemerged with an altered antibiotic resistance pattern. In addition to ampicillin, co-trimoxazole, tetracycline, chloramphenicol, and nalidixic acid, all the recent strains were resistant to norfloxacin, lomefloxacin, pefloxacin, and ofloxacin and showed reduced susceptibility to ciprofloxacin. Pulsed-field gel electrophoresis identified a new clone of S. dysenteriae type 1 that was associated with the recent outbreaks and sporadic cases. Based on the spatial and temporal spread of multidrug-resistant S. dysenteriae type 1, we predict that this clonal type may spread further in this region.
, and recently West Africa (3) . To our knowledge, the last cases of dysentery caused by S. dysenteriae type 1 were reported from eastern India in 1988 (D. Sen, P. Dutta, B. C. Deb, and S. C. Pal, Letter, Lancet ii:911, 1988), and except for one strain in 1995, this serotype was not found again till 2001 (14, 15) . We report here a comparative study of S. dysenteriae type 1 strains isolated from an early dysentery outbreak in 1988 and in recent outbreaks and sporadic cases in eastern India.
From with an attack rate of 17%. For bacteriological examination, 51 stool specimens were collected from dysentery patients from these three affected areas.
Strains of S. dysenteriae type 1 isolated from 904 and 950 acute diarrheal patients with sporadic cases who sought treatment at the Infectious Diseases Hospital (IDH) and B. C. Roy Children's Hospital (BCRCH), Calcutta, respectively, between January and December 2002 were also analyzed in this study. Stool specimens were collected from patients with dysentery, by the use of sterile catheters, into MacCartney bottles or with rectal swabs and tested for common enteric pathogens by standard microbiological techniques (18) . The identity of these isolates was confirmed by biochemical tests (18) . Shigella strains were serotyped with an antiserum kit (Denka Seiken Co., Ltd., Tokyo, Japan).
The antimicrobial susceptibility test was done by the standard disk diffusion method, according to the National Committee for Clinical Laboratory Standards guidelines (12) . The Escherichia coli strain ATCC 25922 was used for quality control. Strains of S. dysenteriae type 1 were tested for susceptibility by using commercially available disks (HiMedia, Mumbai, India, and Difco) of ampicillin (10 g), co-trimoxazole (25 g), chloramphenicol (30 g), nalidixic acid (30 g), ciprofloxacin (5 g), norfloxacin (10 g), lomefloxacin (10 g), pefloxacin (5 g), ofloxacin (5 g), and tetracycline (30 g). MICs of nalidixic acid, norfloxacin, ciprofloxacin, and ofloxacin were determined by the E-test (AB Biodisk, Solna, Sweden).
DNA fingerprinting was done by pulsed-field gel electrophoresis (PFGE) with the restriction enzyme XbaI (Takara Shuzo, Otsu, Japan) according to a standard procedure (4). New and old strains of S. dysenteriae type 1, representing outbreak and sporadic cases, were included for comparison. Run conditions were generated by the autoalgorithm mode of the CHEF Mapper PFGE system with a size range of 30 to 600 kb (Bio-Rad Laboratories, Hercules, Calif.). After electrophore-sis, the ethidium bromide (Sigma, St. Louis, Mo.)-stained agarose gel was visualized and the gel images were digitized for computer-aided analysis (Gel Doc 2000; Bio-Rad) and stored in a personal computer. The images were retrieved and analyzed with the Diversity Database fingerprinting software (Bio-Rad). The differences in the banding patterns of the PFGE profiles were compared to ascertain the clonal relationship between the strains. An unrooted dendrogram was made with the unweighted pair group with arithmetic mean (UPGMA) method. Seventeen strains of Shigella spp. were isolated from the outbreak-affected regions, and sporadic case strains were serologically confirmed as S. dysenteriae type 1. The incidence rate of S. dysenteriae type 1 among sporadic cases was 0.8 and 0.95% in IDH and BCRCH, respectively. No other enteric pathogens were detected from the S. dysenteriae type 1-positive stool specimens. Cyclic epidemic patterns with major shifts in serogroups, with S. dysenteriae type 1 strains initially predominating and subsequently being replaced by S. flexneri, which is then replaced by S. sonnei, have been observed since the turn of the 20th century (7) . This trend seems to be true in Calcutta (1, 14) . Even though other Shigella serotypes prevailed (1, 14) , S. dysenteriae type 1 appeared in this region after a hiatus of 14 years. The incidence of S. dysenteriae type 1 appears to be a recurrent phenomenon, associated with large-scale morbidity and mortality in eastern India Antibiotic susceptibility testing showed that S. dysenteriae type 1 strains were resistant to ampicillin, co-trimoxazole, nalidixic acid, chloramphenicol, and tetracycline (Table 1 ). In addition, the strains isolated in epidemic (2002 to 2003) and sporadic (2002) cases were resistant to norfloxacin, lomefloxacin, ofloxacin, and pefloxacin and showed reduced susceptibil-ity to ciprofloxacin. The MIC ranges of ciprofloxacin, norfloxacin, and ofloxacin for recent S. dysenteriae type 1 strains were found to be 2 to 6, 6 to 24, and 8 to 16 g/ml, respectively ( Table 1) . Antibiotic therapy is essential in the treatment of shigellosis, especially when the patients are infected with S. dysenteriae type 1. In this study, we recorded the isolation of S. dysenteriae strains with unique resistance profiles compared to those isolated previously in this region. The emergence of multidrug-resistant strains of Shigella was previously reported in Bangladesh (16) , Indonesia (8), Tanzania (13) , and India (15) . An interesting observation in this study was the emergence of S. dysenteriae type 1 strains with altered antibiotic resistance profiles during each epidemic in eastern India. Na- (3). Norfloxacin and ciprofloxacin, expanded-spectrum quinolone derivatives, are effective in the treatment of shigellosis (6) . These drugs have helped to control and manage shigellosis in areas of endemicity (10) . The current epidemic is particularly disturbing due to the emergence of S. dysenteriae type 1 strains resistant to norfloxacin and ciprofloxacin, which are the drugs of choice for dysentery. Ampicillin and co-trimoxazole were formerly the drugs of choice for treating shigellosis in developing countries due to their low cost and broad spectrum of activity (13) . These drugs are no longer useful because of the emergence of widespread resistance (16) .
The PFGE patterns of the S. dysenteriae type 1 strains isolated in the 1988 epidemic and a strain isolated in 1995 in a sporadic case in Calcutta differed from those isolated during 2002 and 2003. All the recent epidemic strains were found to be closely related (Fig. 1) , and the strains isolated from patients with sporadic cases admitted to the BCRCH during almost the same time frame exhibited strong similarity to the epidemic strains. However, discrete clones were also detected among patients with sporadic cases from Calcutta (strains BCH518 and NT4359) ( Fig. 1 ). Dendrogram analysis indicated that the 1988 epidemic strains are identical (Fig. 2, cluster A) but different from seven recent epidemic strains (Fig. 2, cluster  B) .
Considering the PFGE clonal criteria (17) , we observed that many strains from patients with sporadic cases were clonally related to epidemic strains isolated during the same period (Table 1) . Chronologically, we first detected a new clone of S. dysenteriae type 1 among 2002 epidemic case patients, followed by sporadic diarrheal case patients admitted to the BCRCH, Calcutta, and in outbreak cases in Mizoram in 2003. This result indicates that the recent multiply drug-resistant strains of S. dysenteriae type 1 are spreading from the outbreak-affected areas to other regions. The reemergence of S. dysenteriae type 1 with epidemic potential is cause for concern. This trend should be carefully monitored in India and neighboring countries.
